期刊文献+

新型血管紧张素Ⅱ1型受体拮抗剂奥美沙坦的内皮保护作用

Protective Effect of New Angiotensin-Ⅱ Subtype 1 Receptor Antagonist Olmesartan Medoxomil on Endothelial Function
下载PDF
导出
摘要 奥美沙坦是一种新型血管紧张素Ⅱ1型受体拮抗剂,近年研究表明除了稳定、持久的降压作用外,它还可通过抑制氧化应激、抑制血管微炎症反应、增加循环内皮祖细胞数量等机制发挥内皮保护效应。现综述了该药对血管内皮功能的保护作用及可能机制。 Olmesartan medoxomil is a new angiotensin Ⅱ subtype 1 receptor antagonist. Apart from its stable, persistent antihypertensive effects, olmesartan medoxomil also has protective effects on endothelial function which may be caused by anti-oxidative stress, inhibition of vascular microinflammation, increase of endothelial progenitor cells, and by other mechanisms. This review summarizes its protective effects and possible meehanism on endothelial function.
作者 高电萨 秦俭
出处 《心血管病学进展》 CAS 2007年第5期809-812,共4页 Advances in Cardiovascular Diseases
关键词 血管紧张素Ⅱ1型受体拮抗剂 奥美沙坦 内皮功能 angiotensin Ⅱ subtype 1 receptor antagonist olmesartan medoxomil endothelial function
  • 相关文献

参考文献26

  • 1Gardener SF,Franks AM.Olmesartan medoxomil:the seventh angiotensin receptor antagonist[J].Ann Pharmacother,2003,37 (1):99-105.
  • 2Laeis P,Puchler K,Kirch W,et al.The pharmacokinetics and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction[J].Hypertension,2001,19(supp1 1):S21-S32.
  • 3von Bergmann K,Laeis P,Puchl ERK,et al.Olmesartan medoxomil:influence of age,renal and hepatic function on the pharmacokinetics of olmesartan medoxomil[J].Hypertension,2001,19(suppl 1):S33-S40.
  • 4No authors listed.Olmesartan for hypertension[J].Med Lett Drus Ther,2002,44(1136):69-70.
  • 5Dzau VJ.Tissue angiotensin and pathobiology of vascular disease:a unifying hypothesis[J].Hypertension,2001,37:1047-1052.
  • 6Takai S,Jin D,Sakaguchi M,et al.The regressive effect of an angiotensin Ⅱ receptor blocker on formed fatty streaks in monkeys fed a high-cholesterol diet[J].Hypertension,2005,23:1879-1886.
  • 7Koike H.New pharmacologic aspects of CS-866,the newest angiotensin Ⅱ receptor antagonist[J].Am J Cardiol,2001,87(8A):33C
  • 8Prasad A,Tupas-Habib T,Schenke WH,et al.Acute and chronic angiotensin-1 receptor antagonism reverses endothelial dysfunction in atherosclerosis[J].Circulation,2000,101:2349-2354.
  • 9Nagai R,Ikeda K,Higashi T,et al.Hydroxyl radical mediates N epsilon-(carboxymethyl)lysine formation from Amadori product[J].Biochem Biophys Res Commun,1997,234:167-172.
  • 10Kato M,Sada T,Mizuno M,et al.Effect of combined treatment with an angiotensin Ⅱ receptor antagonist and an HMG-CoA reductase inhibitor on atherosclerosis in genetically hyperlipidemic rabbits.[J].Cardiovasc Pharmacol,2005,46:556-562.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部